- Home
- NSRX vs ANL Comparison
NSRX vs ANL Comparison
Compare NSRX & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSRX
- ANL
- Stock Information
- Founded
- NSRX N/A
- ANL 2004
- Country
- NSRX
- ANL Cayman Islands
- Employees
- NSRX N/A
- ANL 123
- Industry
- NSRX Biotechnology: Pharmaceutical Preparations
- ANL
- Sector
- NSRX Health Care
- ANL
- Exchange
- NSRX Nasdaq
- ANL Nasdaq
- Market Cap
- NSRX 73.0M
- ANL 62.4M
- IPO Year
- NSRX 2025
- ANL 2023
- Fundamental
- Price
- NSRX N/A
- ANL $1.69
- Analyst Decision
- NSRX
- ANL Hold
- Analyst Count
- NSRX 0
- ANL 1
- Target Price
- NSRX N/A
- ANL N/A
- AVG Volume (30 Days)
- NSRX N/A
- ANL 8.3K
- Earning Date
- NSRX N/A
- ANL 08-26-2025
- Dividend Yield
- NSRX N/A
- ANL N/A
- EPS Growth
- NSRX N/A
- ANL N/A
- EPS
- NSRX N/A
- ANL N/A
- Revenue
- NSRX N/A
- ANL N/A
- Revenue This Year
- NSRX N/A
- ANL N/A
- Revenue Next Year
- NSRX N/A
- ANL N/A
- P/E Ratio
- NSRX N/A
- ANL N/A
- Revenue Growth
- NSRX N/A
- ANL N/A
- 52 Week Low
- NSRX N/A
- ANL $1.10
- 52 Week High
- NSRX N/A
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- NSRX N/A
- ANL 60.71
- Support Level
- NSRX N/A
- ANL $1.48
- Resistance Level
- NSRX N/A
- ANL $1.72
- Average True Range (ATR)
- NSRX 0.00
- ANL 0.12
- MACD
- NSRX 0.00
- ANL 0.03
- Stochastic Oscillator
- NSRX 0.00
- ANL 48.25
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.